Terms: = Ovarian cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx
32 results:
1. HERC4 modulates ovarian cancer cell proliferation by regulating smo-elicited hedgehog signaling.
Zhu Q; Yang X; Lv Y
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130557. PubMed ID: 38181892
[TBL] [Abstract] [Full Text] [Related]
2. Triptolide inhibits epithelial ovarian tumor growth by blocking the hedgehog/Gli pathway.
Hu L; Gao M; Jiang H; Zhuang L; Jiang Y; Xie S; Zhang H; Wang Q; Chen Q
Aging (Albany NY); 2023 Oct; 15(20):11131-11151. PubMed ID: 37851362
[TBL] [Abstract] [Full Text] [Related]
3. [Effects of a novel spermine oxidase inhibitor SI-4650 on proliferation and EMT of human ovarian cancer SKVO-3 cells].
Yang JL; Tian JJ; Zhang H; Chen QY; Lyu YF; Cao CY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Mar; 38(2):175-180. PubMed ID: 36031578
[No Abstract] [Full Text] [Related]
4. Sonic Hedgehog signaling pathway in gynecological and genitourinary cancer (Review).
Kotulak-Chrząszcz A; Kmieć Z; Wierzbicki PM
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907821
[TBL] [Abstract] [Full Text] [Related]
5. The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation.
Monk BJ; Coleman RL; Herzog TJ; Moore KN; O'Malley DM; Randall LM; Slomovitz BM; Eskander R; Pothuri B; Reese LL; Mannel RS; Copeland LJ
Gynecol Oncol; 2021 Jul; 162(1):203-209. PubMed ID: 33722417
[TBL] [Abstract] [Full Text] [Related]
6. Hedgehog Signaling and Truncated GLI1 in cancer.
Doheny D; Manore SG; Wong GL; Lo HW
Cells; 2020 Sep; 9(9):. PubMed ID: 32957513
[TBL] [Abstract] [Full Text] [Related]
7. Interference with smo increases chemotherapy drug sensitivity of A2780/DDP cells by inhibiting the Hh/Gli signaling pathway.
Ma S; Liu D; Tan W; Du B; Liu W; Li W; Jiao Y
J Cell Biochem; 2020 Jun; 121(5-6):3256-3265. PubMed ID: 31904145
[TBL] [Abstract] [Full Text] [Related]
8. Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human cancer Reference panel identifies a malignant signature.
Mhawech-Fauceglia P; Izevbaye I; Spindler T; Wang G; Hwang H; Samrao D; Elishaev E; Maxwell GL; Lawrenson K; Darcy KM
Gynecol Oncol; 2020 Jan; 156(1):6-12. PubMed ID: 31711656
[TBL] [Abstract] [Full Text] [Related]
9. Salpingectomy at the time of hysterectomy for benign gynaecological disease: A comparison of surgical approaches.
Obermair HM; Borg EJ
Aust N Z J Obstet Gynaecol; 2019 Oct; 59(5):725-729. PubMed ID: 31286477
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of Hedgehog Signaling in Fibroblasts, Pancreatic, and Lung Tumor Cells by Oxy186, an Oxysterol Analogue with Drug-Like Properties.
Wang F; Stappenbeck F; Parhami F
Cells; 2019 May; 8(5):. PubMed ID: 31137846
[TBL] [Abstract] [Full Text] [Related]
11. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
Katoh M
Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
[TBL] [Abstract] [Full Text] [Related]
12. The role of the Hedgehog signaling pathway in cancer: A comprehensive review.
Skoda AM; Simovic D; Karin V; Kardum V; Vranic S; Serman L
Bosn J Basic Med Sci; 2018 Feb; 18(1):8-20. PubMed ID: 29274272
[TBL] [Abstract] [Full Text] [Related]
13. Non-canonical Hedgehog signaling activation in ovarian borderline tumors and ovarian carcinomas.
Ozretić P; Trnski D; Musani V; Maurac I; Kalafatić D; Orešković S; Levanat S; Sabol M
Int J Oncol; 2017 Dec; 51(6):1869-1877. PubMed ID: 29039491
[TBL] [Abstract] [Full Text] [Related]
14. Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors.
Stathis A; Hess D; von Moos R; Homicsko K; Griguolo G; Joerger M; Mark M; Ackermann CJ; Allegrini S; Catapano CV; Xyrafas A; Enoiu M; Berardi S; Gargiulo P; Sessa C;
Invest New Drugs; 2017 Dec; 35(6):766-772. PubMed ID: 28317088
[TBL] [Abstract] [Full Text] [Related]
15. DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway.
Singh R; Dhanyamraju PK; Lauth M
Oncotarget; 2017 Jan; 8(1):833-845. PubMed ID: 27903983
[TBL] [Abstract] [Full Text] [Related]
16. Design, synthesis, and biological evaluation of structurally modified isoindolinone and quinazolinone derivatives as hedgehog pathway inhibitors.
Bhattarai D; Jung JH; Han S; Lee H; Oh SJ; Ko HW; Lee K
Eur J Med Chem; 2017 Jan; 125():1036-1050. PubMed ID: 27810591
[TBL] [Abstract] [Full Text] [Related]
17. Tripartite Motif 16 Inhibits the Migration and Invasion in ovarian cancer Cells.
Tan H; Qi J; Chu G; Liu Z
Oncol Res; 2017 Apr; 25(4):551-558. PubMed ID: 27737724
[TBL] [Abstract] [Full Text] [Related]
18. Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.
Ricci F; Fratelli M; Guffanti F; Porcu L; Spriano F; Dell'Anna T; Fruscio R; Damia G
Oncotarget; 2017 Jan; 8(5):7441-7451. PubMed ID: 26910918
[TBL] [Abstract] [Full Text] [Related]
19. Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways: A microarray analysis.
Barkeer S; Guha N; Hothpet V; Saligrama Adavigowda D; Hegde P; Padmanaban A; Yu LG; Swamy BM; Inamdar SR
Glycobiology; 2015 Dec; 25(12):1375-91. PubMed ID: 26347523
[TBL] [Abstract] [Full Text] [Related]
20. Sonidegib: First Global Approval.
Burness CB
Drugs; 2015 Sep; 75(13):1559-66. PubMed ID: 26323341
[TBL] [Abstract] [Full Text] [Related]
[Next]
